Children are as susceptible to the novel coronavirus as adults. In fact, more children have been infected in the second wave of infections in India than the first. In light of this, the government recently came out with guidelines on how to manage Covid-19 in children.
Meanwhile, an expert panel of the country's central drug authority on Wednesday recommended against granting permission to the Serum Institute of India (SII) to conduct the phase 2/3 trial of Covid-19 vaccine Covovax on children aged two to 17 years,